Cacti Asset Management LLC Sells 2,485 Shares of CVS Health Co. (NYSE:CVS)

Cacti Asset Management LLC lessened its position in CVS Health Co. (NYSE:CVSFree Report) by 0.6% in the 4th quarter, Holdings Channel reports. The firm owned 410,360 shares of the pharmacy operator’s stock after selling 2,485 shares during the period. CVS Health accounts for approximately 1.4% of Cacti Asset Management LLC’s investment portfolio, making the stock its 18th biggest holding. Cacti Asset Management LLC’s holdings in CVS Health were worth $18,031,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory acquired a new position in CVS Health during the 3rd quarter worth approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the third quarter valued at approximately $31,000. Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health in the third quarter valued at about $33,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CVS. TD Cowen boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Royal Bank of Canada cut their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Truist Financial restated a “buy” rating and issued a $67.00 price objective (down previously from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. Piper Sandler reduced their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Finally, Mizuho cut their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $69.12.

Read Our Latest Analysis on CVS

CVS Health Price Performance

Shares of NYSE CVS traded down $0.48 during trading hours on Thursday, hitting $44.41. 2,550,079 shares of the stock were exchanged, compared to its average volume of 11,647,537. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $83.25. The company has a market cap of $55.89 billion, a PE ratio of 11.27, a price-to-earnings-growth ratio of 0.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company’s fifty day simple moving average is $53.30 and its two-hundred day simple moving average is $57.30.

CVS Health (NYSE:CVSGet Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. CVS Health’s revenue was up 6.3% on a year-over-year basis. On average, sell-side analysts predict that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.